CYP19A1 and Obesity: Studies of mice with global aromatase deficiency consistently show an increased propensity towards obesity and insulin resistance (94–96), and mice with adipocyte-specific aromatase overexpression exhibit improved insulin sensitivity and reduced inflammation (97).